Keystone Financial Group Inovio Pharmaceuticals, Inc. Transaction History

Keystone Financial Group

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.35 - $0.53 $4,494 - $6,805	12,840 Added 11.68%	122,737 $62,000
Q3 2023 Nov 06, 2023	BUY	$0.38 - $0.58 $1,330 - $2,029	3,500 Added 3.29%	109,897 $42,000
Q2 2023 Aug 07, 2023	BUY	$0.39 - $0.94 $2,772 - $6,682	7,109 Added 7.16%	106,397 $47,000
Q4 2022 Feb 07, 2023	BUY	$1.41 - $2.5 $35,574 - $63,075	25,230 Added 34.07%	99,288 $154,000
Q3 2022 Nov 10, 2022	SELL	$1.66 - $2.79 $189 - $318	-114 Reduced 0.15%	74,058 $128,000
Q2 2022 Aug 05, 2022	BUY	$1.44 - $3.98 $2,520 - $6,965	1,750 Added 2.42%	74,172 $128,000
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $17,820 - $31,200	6,000 Added 9.03%	72,422 $260,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $16,217 - $24,245	3,250 Added 5.14%	66,422 $331,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $17,613 - $23,837	2,460 Added 4.05%	63,172 $452,000
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $27,767 - $44,703	4,457 Added 7.92%	60,712 $563,000
Q1 2021 May 11, 2021	BUY	$8.81 - $16.96 $151,355 - $291,372	17,180 Added 43.97%	56,255 $522,000
Q4 2020 Feb 10, 2021	BUY	$8.5 - $12.85 $56,100 - $84,810	6,600 Added 20.32%	39,075 $346,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $310,785 - $878,448	32,475 New	32,475 $377,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

Stay updated on Keystone Financial Group with notifications on news.